Jonathan Goldberg

ORCID: 0009-0006-4377-0066
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer therapeutics and mechanisms
  • Cancer Immunotherapy and Biomarkers
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • Advanced Breast Cancer Therapies
  • Synthesis and biological activity
  • Mesenchymal stem cell research
  • Angiogenesis and VEGF in Cancer
  • Occupational and environmental lung diseases
  • Monoclonal and Polyclonal Antibodies Research
  • Cardiac Imaging and Diagnostics
  • Metabolism, Diabetes, and Cancer
  • Coronary Interventions and Diagnostics
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pleural and Pulmonary Diseases
  • Immunotherapy and Immune Responses
  • Cancer Cells and Metastasis
  • Hematopoietic Stem Cell Transplantation
  • Aluminum toxicity and tolerance in plants and animals
  • CAR-T cell therapy research
  • Acute Myocardial Infarction Research
  • Tissue Engineering and Regenerative Medicine
  • Protease and Inhibitor Mechanisms
  • Lung Cancer Treatments and Mutations
  • Protein Kinase Regulation and GTPase Signaling

Dana-Farber Cancer Institute
2024

Dana-Farber Brigham Cancer Center
2024

Brigham and Women's Hospital
2024

Duke University
2016-2020

Oxford University Press (United Kingdom)
2020

The University of Texas MD Anderson Cancer Center
2017-2018

Louis Stokes Cleveland VA Medical Center
2012-2017

Massachusetts General Hospital
2016

Clinical Research Institute
2016

University Hospitals Cleveland Medical Center
2012

Insulin receptor substrate (IRS) proteins are important intracellular molecules that mediate insulin tyrosine kinase signaling. A decreased content of IRS has been found in insulin-resistant states animals, humans, and cultured cells under various conditions. However, the molecular mechanism controls cellular levels is unknown. We report chronic treatment induces degradation IRS-1, but not IRS-2, protein cells. The insulin-induced IRS-1 can be prevented by pretreatment with lactacystin, a...

10.2337/diabetes.48.7.1359 article EN Diabetes 1999-07-01

Stimulation of cell signaling cascades by oxidants may be important in the pathogenesis pulmonary and pleural diseases. Here, we demonstrate rat mesothelial cells that apoptotic concentrations crocidolite asbestos H 2 O induce phosphorylation activation extracellular signal-regulated protein kinases (ERK). Activation c- jun-NH -terminal (JNK)/stress-activated was also observed response to . In contrast, caused more protracted ERK without JNK activation. Both - asbestos-induced abolished...

10.1152/ajplung.1997.273.5.l1029 article EN AJP Lung Cellular and Molecular Physiology 1997-11-01
Harmony R. Reynolds Derek D. Cyr C. Noel Bairey Merz Leslee J. Shaw Bernard R. Chaitman and 95 more William E. Boden Karen P. Alexander Yves Rosenberg Sripal Bangalore Gregg W. Stone Claes Held John A. Spertus Kaatje Goetschalckx O.L. Bockeria Jonathan Newman Jeffrey S. Berger Ahmed Elghamaz Renato D. Lópes James K. Min Daniel S. Berman Michael H. Picard Raymond Y. Kwong Robert A. Harrington Boban Thomas Sean M. O’Brien David J. Maron Judith S. Hochman Kreton Mavromatis Jason Linefsky Todd Q. Miller Subhash Banerjee Harmony R. Reynolds Jonathan Newman Sripal Bangalore Robert Donnino Lawrence M. Phillips Muhamed Sarić Khaled Abdul‐Nour Peter H. Stone James J. Jang Gennie Yee Steven Weitz Suzanne V. Arnold James H. O’Keefe Michael D. Shapiro Mohammad El‐Hajjar Mandeep S. Sidhu Steven Fein Mikhail Torosoff Radmila Lyubarova Sulagna Mookherjee Krzysztof Drzymalski Edward O. McFalls Santiago García Stefan Bertog Rizwan A. Siddiqui Areef Ishani Ronnell A. Hansen Michel G. Khouri Jonathan Goldberg Richard S. Goldweit Ronny Cohen Brooks Mirrer Victor J. Navarro David E. Winchester Marvin W. Kronenberg Philip Rogal Christopher McFarren John F. Heitner Ira Dauber Charles R. Cannan Sriram Sudarshan Puja K. Mehta Michael McDaniel Stamatios Lerakis Arshed A. Quyyumi Nanette K. Wenger Chester M. Hedgepeth Heather Hurlburt Alan Rosen Zakir Sahul David T. Booth Steve Leung Ahmed Abdel‐Latif Hassan Reda Khaled M. Ziada Sampoornima Setty Rajat S. Barua Fadi G. Hage Christiano Caldeira James E. Davies Massoud A. Leesar Jaekyeong Heo Amy Iskandrian Firas Al Solaiman Satinder P. Singh Khaled Dajani Mohammad El‐Hajjar Paul Der Mesropian Joseph Sacco

Women with chronic coronary disease are generally older than men and have more comorbidities but less atherosclerosis. We explored sex differences in revascularization, guideline-directed medical therapy, outcomes among patients ischemia on stress testing, without invasive management.

10.1161/jaha.122.029850 article EN cc-by-nc-nd Journal of the American Heart Association 2024-02-27
James Slater David J. Maron Philip G. Jones Sripal Bangalore Harmony R. Reynolds and 95 more Zhuxuan Fu Gregg W. Stone Ruth Kirby Judith S. Hochman John A. Spertus Kreton Mavromatis Jason Linefsky Todd Q. Miller Subhash Banerjee Jonathan Newman Robert Donnino Muhamed Sarić Khaled Abdul-Nour Peter Stone James J. Jang Gennie Yee Steven Weitz Suzanne V. Arnold James H. O’Keefe Michael D. Shapiro Steven Fein Mikhail Torosoff Radmila Lyubarova Sulagna Mookherjee Krzysztof Drzymalski Edward O. McFalls Santiago García Stefan Bertog Rizwan A. Siddiqui Areef Ishani Ronnell A. Hansen Michel G. Khouri Jonathan Goldberg Richard S. Goldweit Ronny Cohen Brooks Mirrer Victor J. Navarro David E. Winchester Marvin W. Kronenberg Christopher McFarren John F. Heitner Ira Dauber Charles R. Cannan Sriram Sudarshan Puja K. Mehta Michael McDaniel Stamatios Lerakis Arshed A. Quyyumi Nanette K. Wenger Chester M. Hedgepeth Heather Hurlburt Alan Rosen Zakir Sahul Steve Leung Hassan Reda Khaled M. Ziada Sampoornima Setty Rajat S. Barua Fadi G. Hage James E. Davies Massoud A. Leesar Jaekyeong Heo Amy Iskandrian Firas Al Solaiman Satinder P. Singh Khaled Dajani Mohammad El‐Hajjar Paul Der Mesropian Joseph Sacco Brian McCandless Marisa Orgera Mandeep S. Sidhu Imran Arif Hanan Kerr Jorge F. Trejo Gerald F. Fletcher Gary E. Lane Lynn M. Neeson Pragnesh Parikh Peter Pollak Brian P. Shapiro Kevin Landolfo Anthony Gemignani Daniel J. O’Rourke Judith Meadows Jason T. Call Joseph Hannan Robert M. Bojar Deepti Kumar John Mukai Edward T. Martin Gabriel Vorobiof Alec J. Moorman Scott Kinlay Robert J. Hamburger

BACKGROUND: The appropriate use criteria for revascularization of stable ischemic heart disease have not been evaluated using randomized data. Using data from the ISCHEMIA trial (International Study Comparative Health Effectiveness with Medical and Invasive Approaches; July 2012 to January 2018, 37 countries), health status benefits an invasive strategy over a conservative one were examined within scenarios. METHODS: Among 1833 participants mapped 36 scenarios, symptom was assessed Seattle...

10.1161/circoutcomes.124.010849 article EN Circulation Cardiovascular Quality and Outcomes 2025-02-26

Abstract Estrogen receptor–positive (ER+) breast cancer is not considered immunogenic and, to date, has been proven resistant immunotherapy. Endocrine therapy remains the cornerstone of treatment for ER+ cancers. However, constitutively activating mutations in estrogen receptor alpha (ESR1) gene can emerge during treatment, rendering tumors endocrine therapy. Although these represent a pathway resistance, they also potential source neoepitopes that be targeted by In this study, we...

10.1158/2767-9764.crc-23-0244 article EN cc-by Cancer Research Communications 2024-02-09

We examined the mechanisms of interaction crocidolite asbestos fibers with epidermal growth factor (EGF) receptor (EGFR) and role EGFR-extracellular signal-regulated kinase (ERK) signaling pathway in early-response protooncogene (c- fos/c- jun) expression apoptosis induced by rat pleural mesothelial (RPM) cells. Asbestos fibers, but not nonfibrous analog riebeckite, abolished binding EGF to EGFR. This was due a direct ligand, inasmuch as studies using absence membranes showed that did adsorb...

10.1152/ajplung.1999.277.4.l684 article EN AJP Lung Cellular and Molecular Physiology 1999-10-01

We developed in situ dual-fluorescence detection techniques for measuring apoptosis and proliferation simultaneously single dishes of cells. The deoxyribonucleic acid (DNA)-specific labeling method, terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate nick-end (TUNEL), first was used conjunction with a 4',6-diamidino-2-phenylindole (DAPI) counterstain to detect measure morphologic characteristics apoptotic rat pleural mesothelial (RPM) cells isolated from Fischer...

10.1165/ajrcmb.17.3.2991 article EN American Journal of Respiratory Cell and Molecular Biology 1997-09-01

In recent years, it has become apparent that minerals can trigger alterations in gene expression by initiating signaling events upstream of transactivation. These cascades may be initiated at the cell surface after interaction with plasma membrane either through receptorlike mechanisms or integrins. Alternatively, pathways stimulated active oxygen species generated both during phagocytosis and redox reactions on mineral surface. At least two linked to activation transcription factors, i.e.,...

10.1289/ehp.97105s51121 article EN public-domain Environmental Health Perspectives 1997-09-01

Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior infarction pre‐ post‐cells. Pigs 90‐minute balloon occlusion left anterior descending artery (LAD). After one week they were...

10.1111/j.1540-8183.2008.00390.x article EN Journal of Interventional Cardiology 2008-09-24

Cathepsin G (CG) is a myeloid azurophil granule protease that highly expressed by acute leukemia (AML) blasts and stem cells. We previously identified CG1 (FLLPTGAEA), human leukocyte antigen-A2-restricted nonameric peptide derived from CG, as an immunogenic target in AML. In this report, we aimed to assess the level of CG expression lymphoid (ALL) its potential immunotherapeutic ALL. Using RT-PCR western blots, mRNA protein, respectively, B-ALL patient samples cell lines. also examined...

10.3389/fimmu.2017.01975 article EN cc-by Frontiers in Immunology 2018-01-25

Objectives To evaluate potential gaps in preventive medical therapy and healthy lifestyle practices among symptomatic patients with suspected coronary artery disease (CAD) seeing primary care physicians cardiologists how vary by sociodemographic characteristics baseline cardiovascular risk. Design Cross-sectional study assessing gaps. Participants 10 003 outpatients evaluated physicians, or other specialists for CAD. Setting PROspective Multicenter Imaging Study Evaluation of Chest Painfrom...

10.1136/bmjopen-2017-016364 article EN cc-by-nc BMJ Open 2017-09-01

<h3>Background</h3> T cells are generally present in low numbers estrogen receptor-positive (ER+) breast cancer (BC), potentially due to limited antigens or impaired antigen presentation. However, the defined mechanisms remain unclear. <h3>Methods</h3> This study investigates interplay between receptor signaling (ERS), presentation machinery (APM), and cell (TC) using diverse datasets, including transcriptome of 54 BC lines CCLE, hundreds patients from TCGA, METABRIC, ACOSOG Z1301B trial (an...

10.1136/jitc-2024-sitc2024.1407 article EN cc-by-nc Regular and Young Investigator Award Abstracts 2024-11-01

&lt;div&gt;Abstract&lt;p&gt;Estrogen receptor–positive (ER&lt;sup&gt;+&lt;/sup&gt;) breast cancer is not considered immunogenic and, to date, has been proven resistant immunotherapy. Endocrine therapy remains the cornerstone of treatment for ER&lt;sup&gt;+&lt;/sup&gt; cancers. However, constitutively activating mutations in estrogen receptor alpha (&lt;i&gt;ESR1&lt;/i&gt;) gene can emerge during treatment, rendering tumors endocrine therapy. Although these represent a pathway resistance,...

10.1158/2767-9764.c.7086978.v1 preprint EN 2024-02-22

&lt;p&gt;Peptide-specific expansion of CD8&lt;sup&gt;+&lt;/sup&gt; T cells. PBMCs from healthy donors were isolated and expanded as described in the Materials Methods. Tetramer staining was performed pre- post-expansion to quantify frequencies peptide-specific &lt;b&gt;A,&lt;/b&gt; Wildtype-1, E380Q. &lt;b&gt;B,&lt;/b&gt; Wildtype-2, Y537S, D538G. Data represents three independent experiments, 3 separate donors, triplicate. Statistical significance determined via comparison pre-expansion...

10.1158/2767-9764.25266564.v1 preprint EN cc-by 2024-02-22

&lt;p&gt;Peptide-specific CTLs effectively kill ER&lt;sup&gt;+&lt;/sup&gt; breast tumor cells. MCF7 cells were pulsed with corresponding peptides and labeled calcein-AM. Cytotoxicity was determined by a standard calcein-AM release assay. peptides. CG1-pulsed non-pulsed used as negative controls. Statistical significance via one-way ANOVA. Data show percent cytotoxicity at the 10:1 effector:target ratio, represent average of five experiments (run in triplicate) from different healthy female...

10.1158/2767-9764.25266558 preprint EN cc-by 2024-02-22
Coming Soon ...